HeartBeam (BEAT) Other Non Operating Income (2021 - 2024)

HeartBeam's (BEAT) quarterly Other Non Operating Income came in at -$150900.0 in Q4 2024, down 2415.0% quarter-over-quarter from -$6000.0 in Q3 2024.

Analysis

HeartBeam (BEAT) Other Non Operating Income (2021 - 2024) Analysis & Trends

HeartBeam (BEAT) has reported Other Non Operating Income for 3 consecutive years, with -$150900.0 the latest figure, recorded in Q4 2024.

On a quarterly basis, Other Non Operating Income changed N/A year-over-year to -$150900.0 in Q4 2024; TTM through Dec 2024 was -$156900.0, a 5330.0% decrease from a year earlier, with the FY2025 full-year figure at $403400.0, up 357.11% from the prior year.
Other Non Operating Income was -$150900.0 for Q4 2024 at HeartBeam, down from -$6000.0 in the prior quarter.
Over five years, Other Non Operating Income peaked at $22000.0 in Q1 2021 and troughed at -$150900.0 in Q4 2024.
A 3-year average of -$32975.0 and a median of -$1500.0 in 2022 frame the typical range for Other Non Operating Income.

Peer Set

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	187.42 Bn	182.47 Bn	7.27 Bn
2	Intuitive Surgical	129.78 Bn	124.69 Bn	1.96 Bn
3	Medtronic	120.53 Bn	112.33 Bn	6.34 Bn
4	Stryker	116.28 Bn	112.80 Bn	4.50 Bn
5	Boston Scientific	69.29 Bn	68.99 Bn	3.85 Bn
6	Edwards Lifesciences	51.83 Bn	47.68 Bn	1.35 Bn
7	Alcon	34.36 Bn	32.91 Bn	1.68 Bn
8	Dexcom	33.17 Bn	31.23 Bn	830.00 Mn
9	Resmed	32.94 Bn	31.47 Bn	861.22 Mn
10	HeartBeam	24.23 Mn	24.23 Mn	-

Historic Data

Download Data